S
SLDB icon

SignatureFD’s Solid Biosciences SLDB Stock Holding History

SignatureFD’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-228
Closed -$1.41K – 3526
2025
Q3 		$1.41K Buy
+228
New +$1.33K ﹤0.01% 3023
2024
Q4 		– Sell
-43
Closed -$300 – 3392
2024
Q3 		$300 Buy
+43
New +$349 ﹤0.01% 3142
2021
Q3 		– Sell
-29
Closed -$2K – 3194
2021
Q2 		$2K Buy
+29
New +$1.92K ﹤0.01% 2617

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SignatureFD's SLDB Position: Q4 2025 in Review

SignatureFD sold out of Solid Biosciences (SLDB) in Q4 2025, closing a stake of 228 shares — an estimated $1.41K sold.

SignatureFD first reported a position in SLDB in Q2 2021 and held it in 3 quarters. The position peaked at $2K in Q2 2021. 130 funds tracked by Wall St. Rank hold SLDB as of Q4 2025.

  • SignatureFD reported no remaining Solid Biosciences position as of Q4 2025 after selling out during the quarter.
  • SignatureFD sold 228 Solid Biosciences shares in Q4 2025, an estimated $1.41K.
  • SignatureFD first reported a position in Solid Biosciences in Q2 2021 and held it in 3 quarters.
  • SignatureFD's Solid Biosciences position peaked at $2K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2025.

Based on SignatureFD's 13F filing for Q4 2025, filed 20 Jan 2026.